newsfilter
← Latest News
Business Wire·

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Company Also Reaches Agreement with Sixth Street Partners to Extend the Maturity Date of its Financing Agreement to September 30, 2022 with the Ability to Extend to November 30, 2022 if Additional Capital is Received TherapeuticsMD, Inc. (NASDAQ:TXMD